Preclinical research suggests BPC-157 may support tendon, ligament, and joint tissue healing, but controlled canine clinical trials remain limited
From Days 3 to 8, the medium was switched to Knockout DMEM, 20% Knockout Serum Replacer, beta-mercaptoethanol (BME, 100 M), 1% Glutamax, non-essential amino acids, and 1% DMSO
In addition to its direct health benefits, AOD9604 aids in creating a more sustainable approach to weight management
(jofem.org) The best-case signal: modest weight loss in a shorter trial A frequently cited 12-week randomized trial result (as summarized in reviews) reported: ~2.6 kg average loss with AOD-9604 1 mg/day vs ~0.8 kg with placebo (PMC) This is the kind of result that can be statistically meaningful, clinically modest, and very sensitive to study design (diet, activity, baseline metabolic status, adherence)